Free Scientist in Hematology - H(ASCP) Practice Questions

Sample Practice Questions

Try these 10 sample questions from the Scientist in Hematology - H(ASCP) practice bank. Each includes the answer and explanation. Continue with the interactive practice above to review the full question set.

1. 1Which change in oxygen availability normally increases renal erythropoietin release?

   1. A. A fall in blood oxygen level
   2. B. A rise in blood oxygen level
   3. C. An increase in platelet activation
   4. D. An increase in red cell destruction alone

   Answer: A

   Explanation: MedlinePlus states, "These cells release more EPO when the blood oxygen level is low." The oxygen decrease is the direct stimulus described for renal EPO release.

   Reference: Erythropoietin test — Overview

2. 2An anemic specimen has microcytic, hypochromic red cells, low ferritin, and high total iron-binding capacity. Which process best fits this pattern?

   1. A. Iron deficiency
   2. B. Anemia of inflammation
   3. C. Sideroblastic iron loading
   4. D. Vitamin B12 deficiency

   Answer: A

   Explanation: Merck states, "Iron deficiency typically causes low serum iron, high iron-binding capacity, and low serum ferritin levels." The stated red cell pattern also fits iron deficiency.

   Reference: Merck Manual Professional: Iron Deficiency Anemia — Diagnosis of Iron Deficiency Anemia

3. 3In an automated complete blood count, which value is directly measured rather than calculated?

   1. A. Hematocrit
   2. B. Mean corpuscular hemoglobin
   3. C. Platelet count
   4. D. Mean corpuscular hemoglobin concentration

   Answer: C

   Explanation: Merck states that the automated CBC "directly measures hemoglobin, RBC count, WBC count, and platelet count" and describes hematocrit, MCH, and MCHC as calculated values. Thus platelet count is the directly measured choice.

   Reference: Evaluation of Anemia - Merck Manual Professional Edition — Complete blood count and RBC indices

4. 4Immediately after vessel trauma, how does the local vascular response help limit blood loss?

   1. A. The injured vessel constricts and reduces local flow
   2. B. The injured vessel dilates and reduces local flow
   3. C. Only distant intact vessels constrict before local flow changes
   4. D. Local vascular tone remains unchanged until fibrin forms

   Answer: A

   Explanation: Merck identifies "local vasoconstriction (an immediate reaction to injury)" as a vascular response limiting blood loss. Local dilation would increase flow, and delaying or relocating constriction misses the immediate local response.

   Reference: Overview of Hemostasis - Merck Manual Professional Edition — Vascular Factors of Hemostasis

5. 5A specimen is mislabeled before a hematology analysis begins. Which testing phase contains this error?

   1. A. Preanalytical phase
   2. B. Analytical phase
   3. C. Postanalytical phase
   4. D. Proficiency-testing phase

   Answer: A

   Explanation: Specimen identification happens before analysis. The source states "Pre-analytic is a part of the total testing process referring to all steps taken prior to the actual testing"

   Reference: Developing an Individualized Quality Control Plan - CMS — Appendix F, glossary, Pre-Analytic Phase

6. 6What initiates erythropoietin receptor signaling during red blood cell production?

   1. A. Binding of erythropoietin to its receptor
   2. B. Binding of thrombopoietin to that receptor
   3. C. Binding of mature hemoglobin to that receptor
   4. D. Binding of circulating platelets to that receptor

   Answer: A

   Explanation: The EPOR description states, "To trigger the production of red blood cells, erythropoietin attaches (binds) to the erythropoietin receptor." The ligand receptor pairing in A initiates the signal.

   Reference: EPOR gene — Normal Function

7. 7A microcytic anemia has target cells and increased hemoglobin A2. Which disease is particularly supported?

   1. A. Beta-thalassemia
   2. B. Iron deficiency anemia
   3. C. Vitamin B12 deficiency
   4. D. Acute hemorrhage

   Answer: A

   Explanation: Merck's thalassemia row lists "Target cells" and "Elevated Hb A2 and Hb F (in beta-thalassemia)." The combination supports beta-thalassemia rather than the other anemia mechanisms.

   Reference: Merck Manual Professional: Evaluation of Anemia — Characteristics of Common Anemias and RBC indices

8. 8For an anemic patient, what physiologic response does the reticulocyte count chiefly help assess?

   1. A. Marrow compensation through red cell production
   2. B. Platelet consumption during coagulation
   3. C. Granulocyte release during infection
   4. D. Plasma volume change after bleeding

   Answer: A

   Explanation: Merck says the reticulocyte count "informs about the response of the bone marrow" and differentiates deficient erythropoiesis from excessive red cell destruction. It therefore evaluates the marrow red cell response, not platelet, granulocyte, or plasma-volume changes.

   Reference: Evaluation of Anemia - Merck Manual Professional Edition — Reticulocyte count

9. 9How do intact endothelial nitric oxide and prostacyclin help maintain blood fluidity?

   1. A. They prevent platelet aggregation and dilate vessels
   2. B. They activate factor X and constrict vessels
   3. C. They cross-link fibrin and constrict vessels
   4. D. They release ADP and aggregate platelets

   Answer: A

   Explanation: Merck states that endothelial nitric oxide and prostacyclin "promote blood fluidity by preventing platelet aggregation and dilating intact blood vessels." The alternatives reverse or misassign these effects.

   Reference: Overview of Hemostasis - Merck Manual Professional Edition — Platelets, endothelial mediators

10. 10A control result is unacceptable during point-of-care testing. What is the control program intended to prompt?

    1. A. Investigate a possible test-performance problem
    2. B. Dismiss the failure if patient values appear plausible
    3. C. Attribute the failed control to the patient's condition
    4. D. Change the reference interval to fit the control

    Answer: A

    Explanation: CDC says, "QC testing is designed to detect problems that might arise because of operator error, reagent or test kit deterioration, instrument malfunction, or improper environmental conditions." A failed control therefore calls attention to assay performance; clinical plausibility, patient condition, and reference intervals do not explain away the control failure.

    Reference: Good Laboratory Practices for Waived Testing Sites - CDC — Recommended Practices During Testing, Quality Control Testing